Neurocrine Biosciences Inc financial data

Symbol
NBIX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6027 Edgewood Bend Court, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 274 % -3.07%
Quick Ratio 5.97 % -13.9%
Debt-to-equity 41.1 % +3.43%
Return On Equity 14.9 % +43%
Return On Assets 10.5 % +41.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +3.4%
Common Stock, Shares, Outstanding 101M shares +3.38%
Entity Public Float 7.9B USD -2.44%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 101M shares +3.28%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +3.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.12B USD +26.7%
Costs and Expenses 1.58B USD +4%
Operating Income (Loss) 536M USD +256%
Nonoperating Income (Expense) -89.3M USD -207%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 447M USD +90.9%
Income Tax Expense (Benefit) 108M USD +86.7%
Net Income (Loss) Attributable to Parent 339M USD +92.3%
Earnings Per Share, Basic 3.44 USD/shares +88%
Earnings Per Share, Diluted 3.36 USD/shares +90.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 140M USD -12.8%
Accounts Receivable, after Allowance for Credit Loss, Current 468M USD +20.8%
Inventory, Net 42.5M USD +34.1%
Other Assets, Current 120M USD +19.5%
Assets, Current 1.67B USD +11.6%
Deferred Income Tax Assets, Net 420M USD +10.7%
Property, Plant and Equipment, Net 80.1M USD +22.1%
Operating Lease, Right-of-Use Asset 263M USD +215%
Intangible Assets, Net (Excluding Goodwill) 33.5M USD -9.21%
Goodwill 5.7M USD 0%
Other Assets, Noncurrent 57.8M USD +61%
Assets 3.31B USD +26.5%
Employee-related Liabilities, Current 59.8M USD
Liabilities, Current 399M USD -31.6%
Accrued Income Taxes, Noncurrent 111M USD
Operating Lease, Liability, Noncurrent 256M USD +188%
Other Liabilities, Noncurrent 121M USD +192%
Liabilities 796M USD +4.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.5M USD
Retained Earnings (Accumulated Deficit) -48.7M USD +87.4%
Stockholders' Equity Attributable to Parent 2.51B USD +35.4%
Liabilities and Equity 3.31B USD +26.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 130M USD
Net Cash Provided by (Used in) Financing Activities 69.9M USD +752%
Net Cash Provided by (Used in) Investing Activities -55M USD -30.6%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 101M shares +3.38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 145M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 148M USD -12.2%
Deferred Tax Assets, Valuation Allowance 88.9M USD +32.7%
Deferred Tax Assets, Gross 530M USD +30.7%
Operating Lease, Liability 292M USD +173%
Depreciation 5.3M USD +29.3%
Payments to Acquire Property, Plant, and Equipment 11.2M USD +31.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 343M USD +82.8%
Lessee, Operating Lease, Liability, to be Paid 381M USD +192%
Property, Plant and Equipment, Gross 154M USD +23.1%
Operating Lease, Liability, Current 35.4M USD +100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 34.9M USD +105%
Lessee, Operating Lease, Liability, to be Paid, Year One 35.4M USD +91.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 89.4M USD +274%
Lessee, Operating Lease, Liability, to be Paid, Year Three 35.8M USD +128%
Deferred Tax Assets, Operating Loss Carryforwards 36.4M USD +32.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 121M USD +43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 36.6M USD +129%
Operating Lease, Payments 6.1M USD +38.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 900K USD 0%
Interest Expense 4.6M USD -17.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%